Ngomhla we-12 kuMatshith 2022, iNMPA (SFDA) ukhuphe isaziso esivuma utshintsho lwesicelo sokuzivavanya imveliso ye-antigen ye-COVID-19 nguNanjing Vazyme BiotechCo., Ltd, Beijing Jinwofu Bioengineering TechnologyCo., Ltd, Shenzhen Huada Yinyuan Pharmaceutical Technology Co., Ltd, I-Guangzhou Wondfo Biotech Co., Ltd kwayeBeijing Savant Biotechnology Co.,ltd(Huakeitayi). Iimveliso ezintlanu zokuzivavanya ze-COVID-19 sele ziqalisiwe.
Ngomhla we-11 kuMatshi ka-2022, i-NHC yabhengeza ukuba, ukuze kuphuculwe ngakumbi isicwangciso sovavanyo lwe-Novel Coronavirus kwaye sifezekise iimfuno zothintelo kunye nolawulo lwe-COVID-19, iQela eliBanzi loThintelo oluDityanisiweyo kunye nolawulo lweBhunga ligqibe ekubeni lidibanise. Uvavanyo lwe-antigen kuvavanyo lwe-nucleic acid kwaye lwenziwa "iProtokholi yeSicelo seNoveli ye-Antigen yokuFumana iCoronavirus (Uvavanyo)"
Iprothokholi ichaza inani elisebenzayo lovavanyo lwe-antigen:
Okokuqala, abo batyelela amaziko ezonyango eziphambili kwaye baneempawu ezifana nepheshana lokuphefumula kunye nomkhuhlane phakathi kweentsuku ezi-5 zokuqala kweempawu;
Okwesibini, abasebenzi abajonga ukuvalelwa bodwa, kubandakanywa ukujongwa kokuvalelwa ekhaya, unxibelelwano olusondeleyo kunye nonxibelelwano olusondeleyo, ukujonga indawo yokuvalelwa, indawo yogcino kunye nabasebenzi bendawo yolawulo;
Okwesithathu ngabahlali basekuhlaleni abanesidingo sokuzifumanisa kwe-antigen.
Iingcebiso: Ukufunyaniswa kwe-Antigen sisongezo esibalulekileyo sokufunyanwa kwe-nucleic acid, kodwa iziphumo zokuzifumanisa kwe-antigen azinakusetyenziswa njengesiseko sokuxilongwa kosulelo.
Ixesha lokuposa: Mar-22-2022